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The Accelerating Effect of Histamine on the
Cutaneous Wound-Healing Process Through
the Action of Basic Fibroblast Growth Factor
Yukikazu Numata1,7, Tadashi Terui2,7, Ryuhei Okuyama1, Noriyasu Hirasawa3, Yoshie Sugiura4,
Ichiro Miyoshi5, Takehiko Watanabe6, Atsuo Kuramasu6, Hachiro Tagami1 and Hiroshi Ohtsu4
This study revealed that the absence of histamine in histidine decarboxylase gene-knockout (HDC/) mice
resulted in delayed cutaneous wound healing and that exogenously administered histamine compensated this
process. With the overproduction of histamine in HDC gene-transgenic mice, the healing was accelerated
compared to the HDCþ /þ mice. These results indicate that histamine positively accelerated the cutaneous
wound healing. Macrophage recruitment and angiogenesis at the wound edge were specifically impaired in
HDC/ mice, and histamine-treated wounds in HDC/ mice demonstrated increased macrophage recruitment
and angiogenesis. The amount of basic fibroblast growth factor (bFGF) in protein level at the wound edge was
higher in HDCþ /þ mice, especially on the 3rd and 5th day of wound healing compared to those in HDC/
mice. Topically administered SU5402, a specific antagonist to fibroblast growth factor receptor-1 tyrosine kinase,
to the wound surface suppressed the wound healing in HDCþ /þ mice but not in HDC/ mice. Moreover,
SU5402 reduced macrophage recruitment and angiogenesis in HDCþ /þ mice. From these observations, it was
concluded that the accelerated wound-healing activity of histamine was mediated by the activity of bFGF, which
leads to angiogenesis, and macrophage recruitment in the wound-healing process.
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INTRODUCTION
The primary function of the skin is to serve as a protective
barrier against the external environment. Loss of the integrity
of large portions of the skin as a result of injury or illness may
lead to major disability or even death. Thus, the amendment
of these cutaneous changes is an important factor for
protecting the body. The cutaneous wound healing is a
complex process encompassing a number of overlapping
events that include leukocyte recruitment, matrix deposition,
epithelialization, and ultimately the resolution of inflamma-
tion with the formation of a mature scar. Normal wound
repair includes a vigorous angiogenic response that delivers
nutrients and inflammatory cells to the injured tissue.
Angiogenesis is an important part of wound healing (Risau,
1997), which involves the induction of proinflammatory
cytokines and various growth factors necessary for this
process (Martin, 1997). Macrophages are reported to regulate
angiogenesis in both normal and diseased or damaged tissues
(Leibovich and Ross, 1975; Koch et al., 1986). Therefore, in
this study, we focused on specific aspects of the wound-
healing process, that is the role of macrophage infiltration,
keratinocyte migration, angiogenesis and basic fibroblast
growth factor (bFGF) under the effect of histamine.
Histamine, which is formed by the decarboxylation of
histidine, possesses many biological activities as an autacoid
and a neurotransmitter (Hill, 1990). Since histamine is also
known to be one of the inflammatory agents, we can
hypothesize that histamine modulates the wound-healing
process. However, it has been difficult to assess the effects of
histamine on the wound-healing process in vivo, because
most observations involve the use of histamine receptor
antagonists and histidine decarboxylase inhibitors. When
using those agents, several problems, are unavoidable
including unknown specificity, selectivity, side effects, and
short half-life. To solve these problems we used histidine
decarboxylase gene-knockout (HDC/)3 mice (Ohtsu et al.,
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2001) and HDC gene-transgenic (HDC-Tg) mice that we have
generated. Here, we report that the presence of histamine
plays an enhancing role in the skin wound-healing process
and in the release of infiltrating macrophages, and that neo-
vascularization was controlled by the growth factor bFGF
after being triggered by histamine.
RESULTS
Effect of histamine on the cutaneous wound healing
The wound size increased on the 1st day after the wounding,
then began to decrease by the 3rd day. The wound was
completely healed in the 2nd or 3rd week. The wound-
healing process was significantly delayed in the HDC/
mice compared with HDCþ /þ mice (Figure 1a and b). The
wound-healing time required for 50% healing was delayed
by 2 days in HDC/ mice compared to HDCþ /þ mice. A
single application of a physiological dose of histamine
(100 nmol/g skin) or 10  of this dose onto the skin defect
resulted in a remarkable acceleration of wound healing in
HDC/ mice (Figure 1c). The addition of histamine to the
skin wounds of HDCþ /þ mice caused a slight acceleration in
the healing process (data not shown). The wound healing in
the HDC-Tg mice was faster than in the wild-type mice
(Figure 1d), and the wound-healing time required for 50%
healing of HDC-Tg mice was 4 days shorter compared to
wild-type mice.
Decreased macrophage number and angiogenesis in the HDC/
mice was restored by local histamine administration
Histologically, on the 1st, 3rd, 5th and 7th day after
wounding, there was no significant difference in re-epithe-
lialization between HDC/ mice and HDCþ /þ mice (Figure
2a and b). In the skin organ culture, the length of the wound
epidermis in HDC/ skin was almost the same as in HDCþ /þ
skin on the 3rd, 5th, and 7th day after culture (Figure 2c
and d). These in vivo and ex vivo data show that the extent
of re-epithelialization was essentially the same in both
genotypes.
Next, we counted the myofibroblasts expressing a smooth
muscle actin (aSMA) (Darby et al., 1990), which are
implicated in contracting the wound edge in the wound-
healing process (Grinnell, 1994). It was difficult to identify
aSMA-positive myofibroblasts before the 7th day of wound-
ing, however, on the 7th day, we found aSMA-positive cells
in the wound (Figure 3a). The aSMA-positive cell number
decreased significantly in HDC/ mice compared to HDCþ /þ
mice (Figure 3b). In addition, we studied transforming growth
factor beta 1 (TGF-b1) expression immunohistochemically,
because it is reported that TGF-b1 plays an important role in
myofibroblast differentiation (Desmouliere et al., 1993). The
number of TGF-b1-positive cells around the wound edge of
HDCþ /þ mice was higher on the 7th day compared to
HDC/ mice, and also the staining was weaker in HDC/
mice (Figure 3a (2nd panels)). After applying histamine to the
wound of HDC/ mice, the TGF-b1-positive cell number
exhibited an increase (Figure 3c).
The F4/80 molecule is a 160-kDa cell surface glycoprotein
expressed at high levels on tissue macrophage (McKnight and
Gordon, 1998). The number of F4/80-positive cells around
the wound edge of HDCþ /þ mice was significantly higher on
the 5th and 7th day compared to the ones in HDC/ mice
(Figure 3d). Macrophage migration to the skin wound was
lower in HDC/ mice but when we applied histamine to the
wound of HDC/ mice, the F4/80-positive cell number
increased to the level in HDCþ /þ mice (Figure 3a (3rd
panels) and d). The vessel numbers and vessel area were
lower in HDC/ mice compared to HDCþ /þ mice,
especially on the 5th and 7th day, but topical application
of histamine again restored the abundance to the HDCþ /þ
level (Figure 3a, e, and f).
The production of bFGF and VEGF at the edge of HDC/ skin
wounds
We have recently reported that vascular endothelial growth
factor (VEGF) is an important angiogenic factors in the
chronic inflammation model (Ghosh et al., 2002). The bFGF
is another potent angiogenic and chemotactic factor for
endothelial cells, fibroblasts, macrophages, and keratino-
cytes, and it stimulates wound healing (Schweigerer et al.,
Day 1
Day 3
Day 5
Day 7
Day 10
+/+ –/– 150
100
*
**
*
*
* *
*
*
*
*
**
50
0
Days after wounding
W
ou
nd
 a
re
a 
(%
)
W
ou
nd
 a
re
a 
(%
)
W
ou
nd
 a
re
a 
(%
)
2 4 6 8 10 12 14
Days after wounding
2 4 6 8 10 12 14
Days after wounding
2 4 6 8 10 12 14
150
100
50
0
125
100
75
50
25
0
+PBS
+/+
HDC-Tg
+Histamine
1 mol/g skin
+Histamine
100 nmol/g skin
+/+
–/–
a b
c
d
Figure 1. Histamine affects on the wound-healing process. (a) Delayed
wound closure is observed in HDC/ mice. Wounds on the 1st, 3rd, 5th, 7th,
and 10th day are shown. (b) Wound areas in HDCþ /þ and HDC/ mice
were determined by tracing the wound margin using a transparent sheet.
Results are means7SEM, n¼8, for each time point and group. *Po 0.05,
**Po0.01 compared with HDCþ /þ mice. (c) Topical effect of histamine on
wound healing of HDC/ mice. Results are means7SEM, n¼ 7 for PBS
group, n¼ 6 for histamine group. *Po0.05 compared with PBS group.
(d) Wound area of wild-type and HDC-Tg mice. Results are means7SEM,
n¼ 6 for the wild-type, n¼ 5 for the HDC-Tg mice. *Po 0.05, **Po0.01
compared with wild-type mice.
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1987; Rifkin and Moscatelli, 1989; Bikfalvi et al., 1997).
Whereas, the bFGF protein expression was significantly
suppressed in HDC/ mice compared to HDCþ /þ mice
on the 3rd and 5th day (Figure 4a), the slight suppression of
VEGF protein expression was statistically insignificant (Figure
4b). Using the reverse transcriptase-PCR method we observed
the mRNA expression of HDCþ /þ and HDC/ mice,
however, no clear differences were observed. The changes
in expression levels depended on the time after wound
making and basically reflected the pattern of the protein
expression (Figure 4c).
Topical application of an angiogenesis inhibitor
Mice treated daily with SU5402, a specific antagonist to
fibroblast growth factor receptor-1 tyrosine kinase, by local
administration caused 1–2 days delay in the time required for
50% healing compared to the control HDCþ /þ group (Figure
5a). The wound sizes of the SU5402-treated group were
significantly larger than those of the HDCþ /þ skin on the
3rd, 5th, and 7th day (Figure 5a), and the number of F4/80-
positive cells at the wound edge was significantly lower on
the 7th day (Figure 5b). The vessel number significantly
decreased on the 7th day after applying SU5402 (Figure 5c),
as well as the percentage of vessel area on the 3rd, 5th, and
7th day (Figure 5d). PTK787, a specific VEGF receptor
antagonist, had little effect on the speed of wound healing in
either HDCþ /þ or HDC/ mice (data not shown).
Topical application of bFGF in HDC/ mice
The bFGF-treated HDC/ group showed significantly faster
wound closure than the non-treated HDC/ group (Figure
S2). The time required for 50% wound healing was 2 days
faster in the bFGF treated group compared to the non-treated
group.
DISCUSSION
In this study, we observed that histamine accelerated the
wound-healing process using three independent approaches
including HDC gene knockout mice, HDC gene transgenic
mice, and topical application of histamine moiety. Clinically,
it is important to reduce the wound area as fast as possible in
order to alleviate stress and reduce the possibility of infection.
Histamine has been expected to influence the wound-healing
process. However, before this study, the role of histamine in
wound healing was controversial, since there were reports
leading to conflicting conclusions; those supporting that
histamine improves the healing process (Fitzpatrick and
Fisher, 1982; Kupietzky and Levi-Schaffer, 1996), others
describing no particular effects on wound healing (Goldman
et al., 1986; Yoshida et al., 1989), and reports indicating the
healing process was impaired by histamine (Kenyon et al.,
1983; Ashida et al., 2001).
Epidermal keratinocyte migration is known to be one of
the pivotal events during cutaneous wound healing (Singer
and Clark, 1999). The keratinocytes at the wound edge
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Figure 2. No difference in re-epithelialization is observed between HDCþ /þ and HDC/ mice. (a) Histological examination of HDCþ /þ and HDC/ mice
on the 3rd, 5th, and 7th day after wounding. The photographs are representative of four wounds stained with hematoxylin and eosin in each group. Asterisks and
dotted lines denote the leading edges of re-epithelialization and the re-epithelialization route, respectively. Arrows indicate the wound edges, which were
defined as described in the Materials and Methods section. (b) The length of the re-epithelialization from the wound edges was analyzed histomorphometrically.
There was no significant difference in the speed of re-epithelialization between HDCþ /þ and HDC/ mice. Results are expressed as the means7SEM, n¼6.
(c) Ex vivo re-epithelialization. Skin explants were cultured and photographed. Arrows indicate the distance of the re-epithelialization. Results were
representative data of three independent experiments. (d) The calculated re-epithelialized area. Results are expressed as the means7SEM, n¼ 3. Bars: (a and c)
1 mm. No significant difference is observed.
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Figure 3. Histological examination of wound-healing process. (a) The skin samples obtained on the 7th day were stained immunohistochemically with anti-
aSMA, anti-TGF-b1, anti-F4/80, and anti-CD31 antibody. Scale bars: 100 mm. (b and c) aSMA- and TGF-b1-positive cells were counted at the wound edges on
the 7th day. (d) The mature macrophages stained with anti-F4/80 antibody were counted at the wound edges on the day of, and 1, 3, 5, 7 days after wounding.
(b, c, and d) Results are means7SEM, n¼ 6. (e) Vessel numbers in the skin lesion were counted after staining with anti-CD31 antibody. (f) Vessel occupancy
ratio in the histology. (e and f) Results are means7SEM, n¼4 except for on the day of wounding and on the 1st day (n¼ 2). *Po0.05, **Po0.01.
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normally start to proliferate behind the actively migrating
cells within hours after the injury (Singer and Clark, 1999).
The keratinocytes migrate between the collagenous dermis
and fibrin eschar through degrading the extracellular matrix
by the proteolytic activities of several types of protease
(Bugge et al., 1996; Romer et al., 1996; Pilcher et al., 1997).
As the re-epithelialization in the wound was not affected by
knocking out the HDC gene in vivo and ex vivo, the delay in
the wound-healing process seemed not to result from a
difference in the speed of re-epithelialization.
Macrophages play a variety of roles in wound healing
including the degradation and elimination of damaged tissue.
The importance of macrophages in wound debridement was
proved using macrophage-depleted guinea pigs (Leibovich
and Ross, 1975) and aged mice (Swift et al., 2001). Therefore
the reduction in the recruitment of macrophages in HDC/
mice is suggested to have contributed to the delay in wound
healing. Macrophages produce various factors with angio-
genic activities. The present study confirmed the simulta-
neous increase of macrophages and neovascularization
during cutaneous wound healing in HDCþ /þ mice. The
induction of angiogenesis had previously been attributed to
acidic or bFGF (Singer and Clark, 1999), but other molecules
have also been found to possess angiogenic activity,
including VEGF (Folkman and D’Amore, 1996; Iruela-Arispe
and Dvorak, 1997). We recently demonstrated in a chronic
inflammatory granulation model that endogenous and
exogenous histamine increased the VEGF expression via the
H2 receptors (Ghosh et al., 2001, 2002). In the wound-
healing model we found to our surprise that bFGF rather than
VEGF was under the control of histamine and stimulating the
vascular formation. Our findings did not exclude the
possibility that other growth factors such as VEGF also
affected angiogenesis. The result of the ELISA analyses
demonstrated that the bFGF expression in HDC/ mice
was remarkably reduced in the skin tissue surrounding the
wound of HDC/ mice. Blood vessel formation was
significantly suppressed by SU5402, but not by PTK787,
suggesting that bFGF participates in angiogenic responses
more actively than VEGF. The importance of bFGF is
supported by observations that VEGF is under the control of
bFGF (Seghezzi et al., 1998; Claffey et al., 2001).
bFGF is known to be produced by various types of cells
such as fibroblasts, keratinocytes, endothelial cells (Kurita
et al., 1992; Takamiya et al., 2003), vascular smooth muscle
cells (Fox and Shanley, 1996), mast cells (Qu et al., 1995.,
1998; Reed et al., 1995), and macrophages (Martin, 1997;
Singer and Clark, 1999; Kibe et al., 2000). We demonstrated
that cell migration at the wound edge was influenced by
histamine, and found that most of the infiltrating cells were
mononuclear cells. Among the infiltrating cells, macrophages
and neutrophils were immunostained with bFGF in the
wound healing (Kibe et al., 2000), which suggests that
macrophages are one of the major sources of bFGF in this
study. Since the delay of wound healing by SU5402 was
exclusively observed in HDCþ /þ mice, it appears that
histamine accelerates the wound healing via fibroblast
growth factor receptor-1 tyrosine kinase.
Skin wound contraction occurring after granulation tissue
formation is an important event reducing the size of the
wound defect. It has been reported that on the 4th day,
fibroblasts transmigrate from the periwound collagenous
matrix of the dermis and the subcutaneous tissue into the
provisional matrix of the wound as part of the granulation
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tissue formation (Greiling and Clark, 1997). Fibroblasts seem
to generate sufficient force to initiate wound contraction (Bell
et al., 1979; Grinnell, 1994; Ehrlich and Rittenberg, 2000).
Moreover, myofibroblasts, which express smooth muscle
actin in their cytosol (Darby et al., 1990), are special forms of
fibroblast implicated in strongly contracting the wound edge
in the wound-healing process (Grinnell, 1994). Therefore, the
delay in wound healing observed in HDC/ mice might be
related to the scarcity of fibroblasts and myofibroblasts.
Our findings prove that endogenously produced or
exogenously administered histamine is important for macro-
phage recruitment and for skin wound healing. One of the
physiological roles of histamine may be an acceleration of
cutaneous wound healing through an enhancement of
angiogenesis and, possibly, by facilitating the exudation of
molecules required for optimal wound healing from the
blood circulation (Wang et al., 1996). Histamine modulates
the endothelial cell proliferation and macrophage recruit-
ment under the effect of bFGF. This novel biological effect
exerted by histamine on the process of skin wound healing
may be amenable to therapeutic manipulation.
MATERIALS AND METHODS
Generation of HDC gene knockout mice and transgenic mice
Age-matched (8–12 weeks old) HDC/ male mice were used (Ohtsu
et al., 2001). The low histamine (0.6 nmol/g) diet (Nihon Nosan,
Japan) are provided ad libitum. HDC-Tg mice were prepared using
the mouse HDC cDNA, in a pCAGGS expression vector (Niwa et al.,
1991) (Figure S1). The histamine levels in the HDC-Tg mouse skin
were increased (500718 (Tg), 384711 nmol/g skin (wild type),
n¼ 4). Northern blot analysis also showed an increase in HDC
mRNA (Figure S1). Studies were performed according to Tohoku
University guidelines for animal use and care.
Generation of skin wounds
Mice were anesthetized by intraperitoneal injection of 0.3 ml of 3%
tribromoethanol (Sigma-Aldrich, St Louis, MO) phosphate-buffered
saline (PBS) solution. The hair on the back was clipped and shaved 2
days before the wound preparation. Full-thickness round skin 5 mm
in diameter was removed using a skin punch device (Maruho, Japan)
as previously described (Matsuda et al., 1998). Each mouse was
housed individually. The wound contour was captured and the area
was calculated using IP-LAB software (Scanalytics Inc., Fairfax, VA).
Histamine dihydrochloride (Sigma-Aldrich) in PBS at a concentra-
tion of 100 nmol or 1 mmol/g skin was applied to the wounds
immediately in order to observe the direct effect of histamine on
wound healing. FGF inhibitor (SU5402, Calbiochem, San Diego,
CA) and VEGF inhibitor (PTK787, donated by Novartis, Switzerland)
were dissolved in 0.2% DMSO of PBS at the time of use up to final
concentration of 75 mg/g skin and 50 mg/g skin, respectively. Human
recombinant bFGF (a gift from Kaken, Japan) was dissolved in
distilled water, and used at a dose of 25 mg/g skin. SU5402, PTK787,
and human recombinant bFGF were applied to the wound with a
transparent occlusive dressing.
Sample preparation
The wound areas were removed and bisected. One half of the tissue
was fixed in 10% formaldehyde and paraffin embedded for the
histological analysis. The other half was snap frozen for immuno-
histochemical study. We dissected the surrounding tissue of the
wound and stored it at 801C for the ELISA assay.
In vivo and in vitro re-epithelialization study
The re-epithelialization speed after wounding was calculated by
histomorphometric analysis (n¼ 6). The wound edge was deter-
mined as the border between the dermis with hair follicles and the
newly developed fibrotic dermis without hair follicles. The extent of
re-epithelialization was defined as the length from the wound edge
to the leading point of keratinocytes.
After washing with PBS, the skin specimens (n¼ 3) including the
epidermis and the upper dermis were placed dermal side down on
the bottom of tissue culture dishes (Stoll et al., 1997) with DMEM
medium containing 10% heat-inactivated fetal bovine serum and 1%
Antibiotic-Antimycotic Solution (Sigma-Aldrich), then cultured at
371C with 5% CO2. The outgrowth of the epithelium was analyzed
using phase contrast microscopy.
Histological and immunohistochemical analysis of wounds
The paraffin sections (n¼ 6) were stained with biotin-conjugated rat
anti-mouse F4/80 (clone A3-1, BMA Biomedicals AG, Switzerland),
rabbit anti-TGF-b1 (Santa Curz) or with monoclonal anti-aSMA
(clone 1A4, Sigma-Aldrich), consecutively the positive cell numbers
were counted. Tissue cryosections (n¼ 4) were stained with biotin-
conjugated rat anti-mouse CD31 (BD Biosciences, San Diego, CA).
Nonimmune rat IgG was used as the control antibody.
ELISA analysis of bFGF and VEGF
The frozen tissue (n¼ 4) was smashed, sonicated and centrifuged at
10,000 g and 41C for 30 minutes. The supernatant was once more
centrifuged at 14,000 g and 41C for 30 minutes. The amount of
protein in the supernatant fraction was determined using a
bicinchoninic acid protein assay kit (Pierce Biotechnology, Rock-
ford, IL) and adjusted to 1 mg/ml. ELISA was performed using bFGF
and VEGF specific ELISA kits (R&D systems Inc., Minneapolis, MN)
according to the manufacturer’s instruction.
Reverse transcriptase-PCR analysis of VEGF and bFGF
The total RNA was extracted from the tissues with Isogen solution
(Nippon Gene, Japan), and was reverse transcribed with AVM
reverse transcriptase (Takara, Japan) according to the manufacturer’s
protocol. The following primers were used; glyceraldehyde-3-
phosphate dehydrogenase: forward primer GAG TAT GTC GTG
GA-30; reverse primer 50-TGG TCC TCA GTG TAG CCC-30, bFGF:
forward primer 50-CAA GCG GCT CTA CTG CAA GAA-30; reverse
primer 50-TCG TTT CAG TGC CAC ATA CCA-30, VEGF: forward
primer 50-CAT CTT CAA GCC GTC CTG TGT-30, reverse primer 50-
AAC GCG AGT CTG TGT TTT TGC-30. After initial denaturation at
951C for 9 minutes, 1 minute cycles at 95, 60, and 721C were
repeated over 27 cycles (glyceraldehyde-3-phosphate dehydrogen-
ase), 35 cycles (VEGF), and 38 cycles (bFGF).
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SUPPLEMENTARY MATERIAL
Figure S1. HDC cDNA transgenic mice.
Figure S2. Exogenously administered bFGF-accelerated wound healing in
HDC/ mice.
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